Full Text
EE292 Cost Effectiveness Analysis of Recombinant Zoster Vaccine Among 50 Years Old and Older in Sweden

Abstract

Authors

E. Zarkadoulas K. Mårdberg M.L. Nishimwe P. Stäck E. Södergren

Back to Volume 26, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×